Released on = July 20, 2006, 10:51 pm

Press Release Author = RNCOS

Industry = Biotech

Press Release Summary = The genomics revolution is introducing fundamental changes
in drug discovery enabling manufacture of better and safer drugs. The major impact
of the drug discovery market is likely to be felt in the Asia Pacific region.

Press Release Body = As budget for the pharmaceutical industry become constrained
and lenient manufacturing gets more and more difficult the industry is pressed to
develop drugs that comply with 'real' value. The evolution of the drug discovery
procedure and introduction of more efficient processes that deliver higher
percentage at a quicker pace paves way to the genomics revolution.

Ushering major changes in drug discovery the genomics revolution is producing
clinical genomics solutions that focus on medical needs, research and development in
pharmaceuticals and support development of improved and safer drugs. As the goals
set for this industry become more striking and compelling, researchers are finding
new ways and measures to ensure higher output.

Within the Asia Pacific drug market, fresh challenges mark their impact of which the
regulatory procedures are major hurdles to the drug discovery process. Regulatory
agencies are extremely cautious about new implementations to maintain efficiency and
safety of drugs. This challenge is likely to make greater influence over the coming
years. It has been found that in 2004, the Asia Pacific drug discovery market
accounted for $5.7Bn, which is expected to touch $18.6Bn by 2011.

RNCOS through its market research report, "Bioinformatics Market Update (2006)"
explains the rapid growth of Bioinformatics Industry Worldwide use of genomics
technologies in the processes of drug screening, drug identification, and drug
validation. It is estimated that the market will grow from $6.3Bn in 2002 to $19.5Bn
by 2010.

The analysts at RNCOS also found that the global Bioinformatics market for
instruments and services for certain drugs and allied products was worth $7.5Bn in
2000. Moving from then to 2005 the revenues increased to $14Bn at an AAGR of 12.0%.

The Research Report on Bioinformatics Industry provides answers for some critical
questions relating to -
-- The current global outlook of Bioinformatics market;
-- The recent developments in the Bioinformatics industry worldwide;
-- The worldwide growth of the Genomics market;
-- The driving forces of the Bioinformatics market;
-- The opportunities for growth and impending threats for the industry; and
-- Comparison between different companies in the Bioinformatics market.

The report is a useful guide for the pharmaceutical companies, IT firms,
biotechnology firms, prospective investors, students and academicians in the field
of Bioinformatics.

About RNCOS:
RNCOS, incorporated in 2002, provides Market Research Reports for your business
needs and aims to put an end to your information pursuit. Our expertise in gathering
global business information for industry research, corporate training, growth
consulting, and business consulting, brings reputed companies and firms to us for
business enhancement solutions. We can be your one-stop-shop for Industry research
information and niche market analysis.

To purchase your copy: http://rncos.com/Report/IM045.htm
For more information about the report please visit www.rncos.com

Web Site = http://www.rncos.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com